Evaluating treatments when a gender by treatment interaction may exist

Statistics in Medicine

Volumn 16, Issue 4, 1997, Pages 455-464

  Russek Cohen, Estelle ^a   Simon, Richard M ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EPIDEMIOLOGICAL DATA; HUMAN; SAMPLING; SEX DIFFERENCE; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

COLONIC NEOPLASMS; CONTROLLED CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MATHEMATICAL COMPUTING; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; RESEARCH DESIGN; SAMPLE SIZE; SEX DISTRIBUTION; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 0031016256     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19970228)16:4<455::AID-SIM382>3.0.CO;2-Y     Document Type: Article

References (13)

1. Wittes, B. and Wittes, J. 'Group therapy', New Republic, 5 April (1993).
2. Congressional Record-House. 'NIH Revitalization Act. Sect. 131', "Inclusion of Women and Minorities in Clinical Research", 20 May, page H2623, 1993.
3. Remington, R. D. and Shork, M. A. Statistics with Applications to the Biological and Health Sciences, 2nd edn, Prentice-Hall, 1985.
4. Cox, D. R. 'Interaction', International Statistical Review, 52, 1-31 (1984).
5. Gail, M. and Simon, R. 'Testing for qualitative interactions between treatment effects and patient subsets', Biometrics, 41, 361-372 (1985).
6. O'Brien, P. and Fleming, T. 'A multiple testing procedure for clinical trials', Biometrics, 35, 549-556 (1979).
7. Genz, A. 'Numerical computation of multivariate normal probabilities', Journal of Computational and Graphical Statistics, 1, 141-149 (1992).
8. Rubinstein, L., Gail, M. and Santner, T. 'Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation', Journal of Chronic Diseases, 34, 469-479 (1981).
9. Schoenfeld, D. A. 'Sample-size formula for the proportional-hazards regression model', Biometrics, 39, 499-503 (1983).
10. Bernstein, L., Anderson, J. R. and Pike, M. C. 'Estimation of the proportional hazard in two-treatment-group clinical trials', Biometrics, 37, 513-520 (1981).
11. Eastern Cooperative Oncology Group. 'Phase III Protocol for the Evaluation of Combined Modalities in the Treatment of Surgically Resected Colonic Carcinoma with Positive Nodes, Dukes' C: 5-FU plus Levamisole versus Postoperative Immunotherapy plus 5-FU plus Levamisole', Protocol E1290, 1993.
12. Simon, R. 'A decade of progress in statistical methodology for clinical trials', Statistics in Medicine, 10, 1789-1818 (1991).
13. NIH Guidelines on the inclusion of women and minorities as subjects in clinical research. Federal Register Part VIII, 28 March (59FR14508-14513), 1994.